S&P 500
(-0.15%) 5 460.94 points
Dow Jones
(-0.12%) 39 066 points
Nasdaq
(0.11%) 17 737 points
Oil
(-0.14%) $80.72
Gas
(-3.70%) $2.65
Gold
(-0.70%) $2 314.50
Silver
(0.18%) $28.92
Platinum
(1.96%) $1 005.70
USD/EUR
(0.32%) $0.936
USD/NOK
(0.73%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(0.01%) $87.50

के लिए वास्तविक समय के अद्यतन Krystal Biotech Inc [KRYS]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
BUY
66.67%
return 2.86%
SELL
28.57%
return 9.59%
अंतिम अद्यतन26 Jun 2024 @ 20:57

-0.99% $ 178.93

खरीदें 102 min ago

@ $177.07

जारी किया गया: 26 Jun 2024 @ 19:16


वापसी: 1.05%


पिछला सिग्नल: Jun 25 - 20:45


पिछला सिग्नल: बेचें


वापसी: -2.62 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:57):
Our systems believe the stock currently is undervalued by 0.22% compare to its pairs and should correct upwards.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States...

Stats
आज की मात्रा 71 168
औसत मात्रा 380 859
बाजार मूल्य 5.11B
EPS $0.0300 ( Q4 | 2024-05-06 )
अगली कमाई की तारीख ( $0.460 ) 2024-08-05
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 82.46
(Sector) 42.63
(Industry) 24.32
ATR14 $3.64 (2.03%)
AADI -2.65%
ABCL 1.59%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 2.71%
ABUS -2.24%
ABVX -3.53%
ACAD -0.51%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL -3.00%
ACHV -1.83%
ACIU -1.00%
ACLX -0.02%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.72%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.58%
AGIO -2.04%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.39%
AKRO -2.81%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -3.90%
ALGS -2.41%
ALKS -0.21%
ALLK -8.47%
ALLO -6.65%
ALLR -3.17%
ALNA 3.16%
ALNY 1.77%
ALPN 0.02%
ALPX 0.00%
ALRN -0.34%
ALT -9.45%
ALVR -0.58%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.50%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.65%
ANPC -3.15%
APGE -1.01%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.00%
APLT -4.50%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.84%
ARDS -14.23%
ARDX -0.66%
ARGX -0.81%
ARNA 0.00%
ARPO -0.90%
ARQT -0.62%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.69%
ARWR -1.86%
ASLN -4.71%
ASMB -7.14%
ASND -0.91%
ATAI -1.11%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 2.91%
ATRA -3.45%
ATXI 1.93%
ATXS -0.89%
AUPH -1.17%
AURA -0.15%
AUTL -1.72%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -5.84%
AVTX -1.25%
AVXL -2.96%
AXLA 0.00%
AXSM -1.75%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.81%
BCAB 3.59%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.15%
BCTX 7.61%
BCTXW -21.24%
BCYC 0.83%
BDRX -3.52%
BDTX -0.85%
BEAM 0.17%
BFRA -2.91%
BGNE -2.72%
BIOR -3.40%
BIVI 1.27%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.52%
BMEA -9.96%
BMRN 0.39%
BNOX -2.22%
BNTC -2.11%
BNTX -1.58%
BOLD -7.90%
BOLT 1.31%
BPMC -1.27%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 23.31%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.33%
CABA 0.62%
CADL -0.97%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 12.13%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.90%
CCCC -5.52%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -3.10%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 4.83%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.99%
CERO -3.40%
CEROW -10.18%
CFRX -27.95%
CGEM -2.50%
CGEN -3.31%
CGON -0.48%
CGTX -5.11%
CHMA -6.00%
CHRS -0.32%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.88%
CLBS -16.75%
CLDX -2.26%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.60%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -8.03%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -40.05%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -3.12%
CORT 2.27%
COYA -1.46%
CPRX -0.86%
CRBP -1.88%
CRBU -4.83%
CRDF -1.77%
CRGX 1.28%
CRIS -0.38%
CRNX -5.70%
CRSP 0.89%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -3.31%
CTNM -0.65%
CTXR 0.04%
CUE 3.81%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 9.75%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.04%
CYTO -2.73%
DARE 7.54%
DAWN 0.60%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 32.19%
DNLI -1.61%
DNTH -6.31%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.52%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.56%
ELOX 7.69%
ELTX -0.88%
ELVN -3.87%
ELYM 1.05%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 5.11%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.44%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.83%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX -0.06%
EXAI -0.94%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.12%
FATE -7.93%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.69%
FBRX -0.04%
FDMT -4.86%
FENC -0.97%
FGEN -5.53%
FHTX 1.43%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.68%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.18%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.42%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.20%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -1.58%
GLYC -10.00%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -9.89%
GOVX 4.99%
GOVXW -49.04%
GPCR -6.49%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.08%
GRTX 0.00%
GTHX 0.45%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -0.89%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.77%
HOOK 1.13%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 1.80%
HSTO 0.00%
HUMA 2.13%
HUMAW -0.01%
IBRX -4.47%
ICCC 0.22%
ICPT 0.21%
ICU 16.82%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.61%
IFRX -1.85%
IGMS -0.15%
IKNA 0.60%
IKT 1.42%
IMAB -0.58%
IMCR -2.61%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.56%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.70%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.66%
INAB 0.00%
INBX 0.46%
INCY -0.95%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 2.66%
INO -1.82%
INSM -0.85%
INTS -2.75%
INVA 0.25%
INZY 0.91%
IOBT -11.42%
IONS 0.36%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -1.95%
IRON -2.79%
ISEE 0.38%
ITOS -1.44%
ITRM 1.67%
IVA 6.96%
IVVD -4.13%
JAGX 1.04%
JANX -4.02%
JAZZ -0.51%
JNCE 0.00%
JSPR -5.92%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.90%
KDNY 0.22%
KMPH -0.34%
KNSA -2.71%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -0.99%
KTRA 16.95%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.62%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.49%
LENZ -4.01%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -10.05%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -4.05%
LPTX -1.10%
LQDA -0.24%
LRMR -1.78%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.35%
LYEL -34.89%
LYRA 2.33%
MACK 0.10%
MBIO -9.07%
MBRX -1.72%
MCRB 1.37%
MDGL -2.42%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.55%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.67%
MNKD -1.05%
MNMD 0.21%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.18%
MORF -3.78%
MREO -4.14%
MRKR 2.68%
MRNA -4.99%
MRNS -4.04%
MRSN -2.85%
MRTX -0.17%
MRUS 0.15%
MRVI -1.82%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.14%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.87%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 5.88%
NKGNW 8.00%
NKTR -3.74%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -0.91%
NMTR -42.97%
NOVN -24.84%
NRBO 12.11%
NRIX -0.29%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.14%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.21%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.29%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.26%
OABIW -10.06%
OBIO -2.99%
OBSV 0.00%
OCEA 0.00%
OCGN 3.81%
OCS -1.02%
OCUL -1.91%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.54%
OMER -1.03%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.09%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.43%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -7.64%
PBYI 1.69%
PCSA 0.00%
PCVX -0.43%
PDSB -1.65%
PEPG -0.60%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.73%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.84%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.22%
PRQR -0.01%
PRTA -2.46%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -0.97%
PTCT -0.50%
PTE -0.82%
PTGX -1.70%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 2.29%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.31%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.10%
RCKT -8.26%
REGN -0.70%
RENB -3.42%
REPL -3.00%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.59%
RIGL -3.28%
RLAY -4.74%
RLMD 0.33%
RLYB -0.34%
RNA -0.59%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.30%
RPTX -2.93%
RUBY 2.70%
RVLP -32.05%
RVMD -1.20%
RVMDW -30.00%
RVNC 2.13%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.20%
RYTM -6.46%
RYZB 0.02%
RZLT 1.69%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -3.97%
SAVA -0.26%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH -0.51%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.03%
SGMT -1.93%
SGTX -2.56%
SIOX 22.63%
SLDB -7.07%
SLGL 4.00%
SLN -4.21%
SLNO -3.74%
SLRX 6.69%
SLS -2.99%
SMMT -2.56%
SNDX 0.84%
SNGX -3.02%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.81%
SRRA 0.00%
SRRK -2.60%
SRZN -2.45%
STAB 0.00%
STOK -5.30%
STRO -2.84%
STSA 0.00%
STTK -4.79%
SURF -0.93%
SVRA -3.03%
SWTX 0.22%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -6.90%
TARS 0.12%
TBPH 0.48%
TCBP 2.73%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.23%
TENX -1.27%
TERN -7.70%
TFFP -3.05%
TGTX -2.94%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -4.13%
TNGX -2.16%
TNXP -6.39%
TNYA -8.23%
TPST 2.43%
TRDA -3.86%
TRVI 1.15%
TRVN 2.92%
TSHA -24.21%
TSVT -3.19%
TTNP -9.27%
TVTX 0.63%
TYRA -7.09%
UBX -2.12%
UNCY -3.73%
URGN -1.46%
UTHR -0.32%
VACC 11.36%
VALN -2.89%
VAXX 99.94%
VBIV 0.78%
VBLT -8.77%
VCEL -0.09%
VCNX 10.35%
VCYT -1.28%
VERA -2.74%
VERU 0.79%
VERV -3.06%
VIGL 5.11%
VINC 1.62%
VIR 0.00%
VIRI -1.57%
VIRX 2.40%
VKTX -1.63%
VLON -13.04%
VNDA -2.12%
VOR -2.02%
VRCA -0.07%
VRDN -4.31%
VRNA -1.40%
VRPX 0.38%
VRTX 0.35%
VSTM -3.74%
VTGN -0.45%
VTVT -2.97%
VTYX -0.21%
VXRT -2.59%
VYGR -1.66%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.40%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -3.11%
XERS 2.62%
XFOR 2.86%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.14%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.51%
ZNTL -2.62%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-11 Krishnan Suma Sell 1 100 Common Stock
2024-06-11 Krishnan Suma Sell 1 882 Common Stock
2024-06-11 Krishnan Suma Sell 1 318 Common Stock
2024-06-11 Krishnan Suma Sell 4 000 Common Stock
2024-06-11 Krishnan Suma Sell 4 550 Common Stock
INSIDER POWER
-68.29
Last 100 transactions
Buy: 51 800 | Sell: 265 300
सहसंबंध (AI algo v.1.1b): Undervalued: 0.22% $179.32 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.85 (strong)
छोटा: -0.08 (neutral)
Signal:(59) Neutral

Krystal Biotech Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
TRVI0.925
APLT0.922
NNOX0.915
KELYA0.914
HOOD0.91
BCYC0.91
TSHA0.905
ACVA0.902
OSS0.901
BTF0.899
10 सबसे अधिक नकारात्मक सहसंबंध
DBX-0.941
SABR-0.935
RAPT-0.934
ROKU-0.918
MFIN-0.909
SSP-0.881
FIVN-0.869
AUPH-0.865
CYAN-0.863
GASS-0.862

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Krystal Biotech Inc सहसंबंध - मुद्रा/वस्त्र

The country flag -0.42
( neutral )
The country flag -0.31
( neutral )
The country flag -0.28
( neutral )
The country flag -0.18
( neutral )
The country flag -0.14
( neutral )
The country flag 0.43
( neutral )

Krystal Biotech Inc वित्तीय

Annual 2023
राजस्व: $50.70M
सकल लाभ: $42.60M (84.02 %)
EPS: $0.400
FY 2023
राजस्व: $50.70M
सकल लाभ: $42.60M (84.02 %)
EPS: $0.400
FY 2022
राजस्व: $0
सकल लाभ: $-4.05M (0.00 %)
EPS: $-5.49
FY 2021
राजस्व: $0.00
सकल लाभ: $0.00 (0.00 %)
EPS: $-3.13

Financial Reports:

No articles found.

Krystal Biotech Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Krystal Biotech Inc

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.7049198150635 seconds
Number of API calls: 3
Number of DB calls: 9